These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 30978400)
1. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase. Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400 [TBL] [Abstract][Full Text] [Related]
2. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE. Kovarik Z; Maček N; Sit RK; Radić Z; Fokin VV; Barry Sharpless K; Taylor P Chem Biol Interact; 2013 Mar; 203(1):77-80. PubMed ID: 22960624 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases. Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869 [TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase. Gorecki L; Gerlits O; Kong X; Cheng X; Blumenthal DK; Taylor P; Ballatore C; Kovalevsky A; Radić Z J Biol Chem; 2020 Mar; 295(13):4079-4092. PubMed ID: 32019865 [TBL] [Abstract][Full Text] [Related]
5. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Kassa J; Kuca K; Karasova J; Musilek K Mini Rev Med Chem; 2008 Oct; 8(11):1134-43. PubMed ID: 18855728 [TBL] [Abstract][Full Text] [Related]
6. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies. Lo R; Chandar NB; Ghosh S; Ganguly B Mol Biosyst; 2016 Apr; 12(4):1224-31. PubMed ID: 26879641 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase. Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933 [TBL] [Abstract][Full Text] [Related]
8. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases. Kuca K; Cabal J; Jun D; Musilek K Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453 [TBL] [Abstract][Full Text] [Related]
9. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. Katalinić M; Šinko G; Maček Hrvat N; Zorbaz T; Bosak A; Kovarik Z Toxicology; 2018 Aug; 406-407():104-113. PubMed ID: 29772260 [TBL] [Abstract][Full Text] [Related]
10. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies. Lo R; Ganguly B Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273 [TBL] [Abstract][Full Text] [Related]
11. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds. Maxwell DM; Brecht KM; Sweeney RE Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773 [TBL] [Abstract][Full Text] [Related]
12. In silico studies on the role of mutant Y337A to reactivate tabun inhibited mAChE with K048. Chandar NB; Ghosh S; Lo R; Banjo S; Ganguly B Chem Biol Interact; 2015 Dec; 242():299-306. PubMed ID: 26494532 [TBL] [Abstract][Full Text] [Related]
13. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats. Kassa J; Jun D; Kuca K J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811 [TBL] [Abstract][Full Text] [Related]
14. Application of a dynamic in vitro model with real-time determination of acetylcholinesterase activity for the investigation of tabun analogues and oximes. Worek F; Herkert NM; Koller M; Thiermann H; Wille T Toxicol In Vitro; 2015 Dec; 30(1 Pt B):514-20. PubMed ID: 26368669 [TBL] [Abstract][Full Text] [Related]
15. In vitro reactivation of acetylcholinesterase using the oxime K027. Kuca K; Kassa J Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409 [TBL] [Abstract][Full Text] [Related]
16. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase. Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948 [TBL] [Abstract][Full Text] [Related]
17. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies. Ghosh S; Chandar NB; Jana K; Ganguly B J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405 [TBL] [Abstract][Full Text] [Related]
18. In vitro investigation of efficacy of new reactivators on OPC inhibited rat brain acetylcholinesterase. Atanasov VN; Petrova I; Dishovsky C Chem Biol Interact; 2013 Mar; 203(1):139-43. PubMed ID: 23220589 [TBL] [Abstract][Full Text] [Related]
19. Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase. Musilek K; Holas O; Jun D; Dohnal V; Gunn-Moore F; Opletalova V; Dolezal M; Kuca K Bioorg Med Chem; 2007 Nov; 15(21):6733-41. PubMed ID: 17764957 [TBL] [Abstract][Full Text] [Related]
20. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication. Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]